Erste Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Erste Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58.1M	Sell	110,210 -50,000	-31%	-$25.6M	0.45%	47
2026 Q1	$81M	Buy	160,210 +19,110	+14%	+$9.13M	0.75%	28
2025 Q4	$82.3M	Sell	141,100 -60,000	-30%	-$30.6M	0.69%	32
2025 Q3	$89.1M	Hold	201,100	–	–	0.86%	20
2025 Q2	$60.8M	Buy	201,100 +36,700	+22%	+$10.9M	0.51%	42
2025 Q1	$54.4M	Hold	164,400	–	–	0.7%	37
2024 Q4	$51.3M	Sell	164,400 -70,000	-30%	-$19.7M	0.63%	40
2024 Q3	$49.7M	Sell	234,400 -10,980	-4%	-$2.81M	0.6%	44
2024 Q2	$68.9M	Sell	245,380 -5,245	-2%	-$1.25M	0.91%	25
2024 Q1	$66.6M	Sell	250,625 -74,375	-23%	-$17.5M	0.91%	25
2023 Q4	$75.3M	Buy	325,000 +74,600	+30%	+$13.1M	1.1%	13
2023 Q3	$36.7M	Buy	250,400 +239,400	+2,176%	+$45.1M	0.63%	48
2023 Q2	$2.42M	Hold	11,000	–	–	0.04%	265
2023 Q1	$2.58M	Hold	11,000	–	–	0.05%	270
2022 Q4	$3.26M	Buy	+11,000	New	+$1.08M	0.07%	244

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Erste Asset Management's MDGL Position: Q2 2026 in Review

Erste Asset Management reduced its Madrigal Pharmaceuticals (MDGL) stake by 31% in Q2 2026, selling an estimated $25.6M and leaving 110,210 shares worth $58.1M. The position accounts for 0.45% of the portfolio, ranked #47.

Erste Asset Management first reported a position in MDGL in Q4 2022 and has held it in 15 quarters since. The position peaked at $89.1M in Q3 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Erste Asset Management held 110,210 shares of Madrigal Pharmaceuticals worth $58.1M as of Q2 2026.
Erste Asset Management sold 50,000 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $25.6M.
Madrigal Pharmaceuticals made up 0.45% of Erste Asset Management's portfolio in Q2 2026, its #47 holding.
Erste Asset Management first reported a position in Madrigal Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
Erste Asset Management's Madrigal Pharmaceuticals position peaked at $89.1M in Q3 2025.
414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.